Stocks · Health care · Pharmaceutical Preparations

Kura Oncology, Inc.

KURA Clue Score49
United States Fiscal year ends December CIK 0001422143 Results filed 12 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Troy Edward Wilson
23 Mar 2026
President and CEO
Exercised, kept
6,103
$6.15
$37.53K
Thomas Malley
18 Mar 2026
Director
Exercised, kept
10,000
$3.12
$31.20K
Troy Edward Wilson
1 Dec 2020
President and CEO
Exercised, kept
11,855
$6.15
$72.91K
Troy Edward Wilson
11 Feb 2020
President and CEO
Exercised, kept
26,911
$4.80
$129.17K
Troy Edward Wilson
11 Feb 2020
President and CEO
Exercised, kept
1,185
$6.15
$7.29K
Troy Edward Wilson
6 Nov 2018
President and CEO
Exercised, kept
26,041
$4.80
$125.00K
Troy Edward Wilson
22 Aug 2017
President and CEO
Exercised, kept
27,985
$4.80
$134.33K
Troy Edward Wilson
21 Apr 2017
President and CEO
Exercised, kept
5,000
$4.80
$24.00K

What was left out

Form 4 filings counted 220
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 18
Sales straight out of an exercise 31
Sales at will 62
Transactions with no price 0
Shares from compensation/vesting 6,262,237
Sales filed before the plan box existed 11
History held since 10 Mar 2015